CLEC2D and oral cavity squamous cell carcinoma: Similarly, CD161 interacts with its receptor LLT1 to regulate the oral squamous cell carcinoma (OSCC) tumor immune microenvironment, thereby improving the prognosis of OSCC patients (Hu et al., 2024).